Reuters Health News Summary

Following is a summary of current health news briefs. Insomnia common among cancer patients

Roughly half of patients with cancer have symptoms of insomnia, and many may have sleep problems that linger for at least a year, a small study suggests. Up to 10 percent of adults in the developed world suffer from chronic insomnia, and cancer patients are particularly prone to it, researchers note in Sleep Medicine. Even though sleep disorders have been tied to worse outcomes for cancer patients, research to date on hasn't offered a clear picture of what circumstances might make sleep problems more likely in people being treated for tumors. Johnson & Johnson wins U.S. FDA approval for bladder cancer drug

Johnson & Johnson's drug Balversa won U.S. approval as the first targeted therapy for advanced bladder cancer, the Food and Drug Administration announced on Friday. The list price of the drug, known chemically as erdafitinib, will range between $10,080 to $22,680 for a 28-day supply, depending of the dose, J&J said. Caito Foods recalls fresh cut melon over Salmonella outbreak

An Indianapolis food company has voluntarily recalled fresh cut melon produced at its facility after reports of nearly 100 illnesses tied to Salmonella contamination. Caito Foods LLC, a unit of SpartanNash Co., suspended production and distribution of pre-cut watermelon, honeydew melon, cantaloupe and mixed fruit containing one of those melons, the U.S. Food and Drug Administration said in a statement issued on Friday. Clovis Oncology halts mid-stage bladder cancer trial, shares drop

Clovis Oncology Inc said on Friday it was halting a mid-stage trial testing its lead drug in bladder cancer patients, sending shares down 12 percent. The company said its decision to discontinue the trial was based on recommendations of an independent committee, which suggested that the treatment may not provide a meaningful benefit to patients. FDA pulls up Walmart, Kroger, others for selling tobacco to minors

The U.S. Food and Drug Administration (FDA) said on Friday it has sent letters to Walmart Inc, Kroger Co and 10 other convenience store chains for selling tobacco products to minors. In the letters, dated April 5, the FDA asked the companies to submit a plan of action within 30 days, describing how they will address and mitigate illegal sales to minors.